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Caloric restriction (CR) has been shown to pre-
vent the onset of insulin resistance and to delay
age-related physiological decline in mammalian
organisms. SIRT1, a NAD+-dependent deacetylase
enzyme, has been suggested to mediate the adap-
tive responses to CR, leading to the speculation
that SIRT1 activation could be therapeutically used
as a CR-mimetic strategy. Here, we used a mouse
model of moderate SIRT1 overexpression to test
whether SIRT1 gain of function could mimic or boost
the metabolic benefits induced by every-other-day
feeding (EODF). Our results indicate that SIRT1
transgenesis does not affect the ability of EODF to
decrease adiposity and improve insulin sensitivity.
Transcriptomic analyses revealed that SIRT1 trans-
genesis and EODF promote very distinct adaptations
in individual tissues, some of which can be even
be metabolically opposite, as in brown adipose tis-
sue. Therefore, whereas SIRT1 overexpression and
CR both improve glucose metabolism and insulin
sensitivity, the etiologies of these benefits are largely
different.INTRODUCTION
The increasing prevalence of obesity, cardiovascular disease,
and type 2 diabetes mellitus in modern societies is heavily influ-
enced by environmental and behavioral cues. Increased caloric
intake and decreased physical activity are associated with a
higher susceptibility to develop metabolic disorders. In
contrast, calorie restriction (CR), either as reductions in daily
caloric intake to 40% below ad libitum (AL) levels or as
every-other-day feeding (EODF), can delay the onset of meta-
bolic and age-related diseases in a wide variety of organisms,
including primates (Mercken et al., 2012). On practice, howev-
er, adherence to a CR regime is difficult in humans. Therefore,
there is a high interest in understanding the mechanisms under-2068 Cell Reports 14, 2068–2075, March 8, 2016 ª2016 The Authorslying CR in order to develop strategies that mimic or amplify its
benefits.
SIRT1 is a NAD+-dependent protein deacetylase and the best
studied mammalian homolog of Sir2, a protein that influences
longevity in yeast. In mammals, a 40% reduction in daily caloric
intake leads to SIRT1 activation in diverse cells and tissues,
including muscle, brain, and adipocytes (Chen et al., 2008; Co-
hen et al., 2004). SIRT1 deficiency leads to dwarfism, metabolic
inefficiency, and failure to metabolically and behaviorally adapt
to multiple CR regimes (Boily et al., 2008; Chen et al., 2005;
McBurney et al., 2003; Mercken et al., 2014). In addition, CR fails
to enhance rodent lifespan in SIRT1 knockout (KO) mice
(Mercken et al., 2014). This evidence suggests that SIRT1 is
required for multiple adaptations to CR in mice. However,
whether SIRT1 activation is enough to mimic CR remains un-
clear. While the specificity of small-molecule SIRT1 activators
(STACs), including resveratrol, has been called into question (Pa-
cholec et al., 2010), their administration to aged mice leads to
overlapping effects with CR, as it reduces age-related physical
decline and mimics gene expression patterns induced by
both EODF and canonical CR (Pearson et al., 2008). Here, we
explored whether SIRT1 moderate overexpression, as a refined
SIRT1 gain-of-function model, could mimic or boost the meta-
bolic benefits of EODF in mice. We demonstrate that EODF ad-
aptations are not enhanced by a moderate SIRT1 overexpres-
sion. Furthermore, our results indicate that, while both SIRT1
overexpression and EODF led to improvements on glucose
metabolism, the origin of these benefits is different.RESULTS
CR, SIRT1 Transgenesis, and Insulin Sensitivity in Mice
Wild-type (WT) and SIRT1Tg/Tg (Tg) mice were fed AL or sub-
jected to EODF during 12 weeks. Body weight (BW) evolution
was followed weekly during the experiment. EODF mice ate
40% more during their meal day, leading to an overall 30%
decrease in caloric intake over 48 hr, with no differences be-
tween genotypes (Figure 1A). Whereas the BW of mice fed AL
increased during the 12-week period, the mice under EODF
maintained their BW around their initial values (Figure 1B). The
changes in BW and composition induced by EODF were similar
Figure 1. SIRT1 Overexpression Does Not Mimic the Beneficial Effects of EODF
12-week-old WT and Tg mice were fed AL or submitted to EODF during 12 weeks (named as WT, WT-EODF, Tg, or Tg-EODF).
(A and B) Food intake (A) and body weight evolution (B) during the experiment.
(C) Body composition was evaluated by EchoMRI 14 weeks after the initiation of EODF.
(D) eWAT weight, measured upon sacrifice.
(E) H&E staining on liver, BAT, and eWAT. Scale bars, 100 mm.
(F) Liver tissue was extracted upon sacrifice, and triglyceride levels were evaluated as described in the Supplemental Experimental Procedures.
All values are presented asmean ± SEM of n = 6–12mice for each genotype and group. $p < 0.05, significant difference between genotypes. *p < 0.05, significant
difference between AL- and EODF-fed mice; ***p < 0.01, significant difference between AL- and EODF-fed mice.in Tg and WT mice (Figures 1B and 1C). The lower fat mass con-
tent in EODF mice was paralleled by a reduction of the epidid-
ymal white adipose tissue (eWAT) weight (Figures 1C and 1D),
associated with an evident decrease in the adipocyte size (Fig-
ure 1E). EODF also lowered hepatic lipid accumulation, as indi-
cated by decreased triglyceride (TG) content and lipid droplet
size (Figures 1E and 1F). While no differences in TG content
were observed between WT and Tg mice fed AL (Figure 1F),
Tg mice displayed a slightly more pronounced decrease of
TG content in the liver upon EODF (Figure 1F). As previouslyCedescribed (Boutant et al., 2015), the brown adipose tissue
(BAT) of Tg mice was characterized by reduced lipid droplet
size (Figure 1E). Surprisingly, EODF markedly increased lipid
droplet size in both WT and Tg mice (Figure 1E), rendering BAT
histological appearance similar between genotypes.
Diverse CR regimes have been shown to increase the activity
and decrease the heat production of mice (Bartfai and Conti,
2012; Chen et al., 2005), which was confirmed in our WT and
Tg mice under the EODF paradigm (Figures 2A and 2B). This
decreased heat production is in line with the increased lipidll Reports 14, 2068–2075, March 8, 2016 ª2016 The Authors 2069
droplet size in the BAT of EODF mice (Figures 1E and 2B).
Conversely, a clear tendency (p = 0.06) toward increased heat
production in AL-fed Tg mice was observed during the light
phase (Figure 2B), in line with the lower size of their BAT lipid
droplets (Figure 1E) and with the higher daily energy expenditure
of these animals (Boutant et al., 2015). CR also has a strong
impact on glucose homeostasis (Mercken et al., 2012). In agree-
ment, glucose tolerance and insulin sensitivity were highly
improved in EODF mice (Figures 2C and 2D). While Tg mice dis-
played enhanced glucose tolerance and insulin sensitivity when
fed AL, the glucose excursion curves after a glucose or an insulin
tolerance test were similar betweenWT and Tgmice upon EODF
(Figures 2C and 2D; Figure S1). These data suggest that EODF
prevents BW gain and improves insulin sensitivity similarly in
WT and Tg mice.
Tg mice display enhanced glucose tolerance due to a higher
insulin response in BAT (Boutant et al., 2015). In order to evaluate
whether EODF prompted similar adaptations, we performed
hyperinsulinemic-euglycemic clamps comparing AL and EODF
mice. As expected, EODF improved insulin sensitivity and led
to dramatic increases in glucose infusion rates in order to main-
tain euglycemia during the clamp (Figure 2E). This was due to a
larger ability of insulin to inhibit hepatic glucose output in EODF
mice, as well as to higher glucose disposal by peripheral tissues
(Figures 2F and 2G), most particularly, WAT and skeletal muscle
(Figure 2G). Surprisingly, EODF led to an 45% decrease in in-
sulin-stimulated glucose uptake in BAT (Figure 2G). This is in op-
position to the observations in Tg mice (Boutant et al., 2015) and
fits the contradictory histologic appearance of the BAT from
EODF and Tg mice (Figure 1E). These observations provide evi-
dence that EODF and SIRT1 trigger benefits on glucose homeo-
stasis via different mechanisms.
The Effects of CR and SIRT1 Transgenesis on
Mitochondrial Function
Next, we evaluated whether EODF altered SIRT1 expression. In
contrast to 40% CR protocols (Chen et al., 2008; Cohen et al.,
2004), EODF did not modulate SIRT1 protein content (Figure 3A;
Figure S2A). In all tissues tested, SIRT1 was predominantly
found as a cytosolic protein, to the point that SIRT1 was almost
undetectable in the nuclear fraction of BAT and muscle (Figures
S2B and S2C; data not shown). EODF did not alter SIRT1 distri-
bution, at least in liver tissue (Figure S2D). Similarly, SIRT1 was
almost exclusively localized in the cytosol of WT or Tg primary
brown adipocytes, and its levels and localization were not
affected by glucose availability (Figure S2E).
Next, to assess SIRT1 activity, we tested the acetylation status
of two well-established SIRT1 targets, RelA/p65 necrosis factor
kB (NFkB) and the peroxisome-proliferator-activated receptor
(PPAR) g coactivator 1a (PGC-1a), in different tissues. In
general, Tg tissues displayed a lower acetylation state of these
substrates, in line with higher SIRT1 activity (Figures S2F and
S2G). These effects, however, were more robust in liver than in
adipose tissues, while skeletal muscle displayed the more
modest effects (Figures S2F and S2G). This might be explained
by the differences in SIRT1 protein levels between tissues
(Figure S2H), as the absolute increase in SIRT1 protein levels
induced by transgenesis was proportional to levels at baseline2070 Cell Reports 14, 2068–2075, March 8, 2016 ª2016 The Authors(Figure S2H). EODF had limited effects on hepatic PGC-1a acet-
ylation levels, but not on RelA/p65 NFkB (Figures S2F and S2G).
Importantly, EODF might lead to lower SIRT1 activity in muscle
and BAT, as evidenced by the higher acetylation state of
PGC-1a and RelA/p65 acetylation under these circumstances
(Figures S2F and S2G).
Increased mitochondrial function has been proposed to be a
mechanism by which CR promotes health benefits (Nisoli
et al., 2005). Hence, we explored how EODF and SIRT1 trans-
genesis affected mitochondrial function through respirometry
analyses in liver, BAT, eWAT, and skeletal muscle. In our proto-
col, we evaluated Complex I (CI) respiration, Complex I + Com-
plex II (CI + CII) respiration, and maximal electron transport sys-
tem (ETS) capacity. In skeletal muscle, neither EODF nor SIRT1
transgenesis affected respiratory function (Figure 3B). We also
confirmed previous observations indicating a higher CII activity
in the livers from Tg mice (Boutant et al., 2015) (Figure 3B). Sur-
prisingly, EODF blunted the higher CII activity in Tg livers (Fig-
ure 3B). This was not associated with alterations in CII protein
levels (Figure 3A), suggesting possible roles for post-transla-
tional modifications in the regulation of liver CII activity in Tg
mice. In the BAT, as reported (Boutant et al., 2015), SIRT1 trans-
genesis increased respiratory capacity inmice fedAL (Figure 3B).
However, EODF abolished the effect of SIRT1 overexpression on
BAT respiration (Figure 3B), both in the coupled state and in the
uncoupled state (data not shown). The decrease in BAT oxidative
capacity in EODF mice is in line with their higher lipid accumula-
tion (Figure 1E). Finally, in eWAT, EODF enhanced respiration
rates, in association with an increase in CI protein levels both
in WT and Tg mice (Figures 3A and 3B). These results illustrate
how EODF enhances mitochondrial respiration in eWAT, but
not in liver, BAT, or skeletal muscle. Furthermore, SIRT1 overex-
pression neither mimics nor boosts the effect of EODF on mito-
chondrial respiration. In BAT, EODF actually opposes the effects
of SIRT1 transgenesis.
Comparing SIRT1Tg/Tg Gene Expression Profiles to
Those of CR and Exercise Training
SIRT1 activation has been proposed to act as a CR-mimetic
strategy. If this was true, the transcriptomic landscapes in Tg
mice should display considerable similarities to those of WT
mice upon CR or EODF. Hence, we used microarray technolo-
gies and hierarchical clustering to interrogate how the gene
expression patterns in liver, eWAT, BAT, or skeletal muscle of
Tg mice resembled those of WT mice fed AL or under EODF
(WT-EODF). We also included an additional group in which WT
mice underwent exercise training (EX) for 12 weeks (Figure S3A),
to account for another lifestyle intervention, unrelated to CR, that
reduces BW and improves glucose homeostasis (Mercken et al.,
2012). The efficacy of our training intervention was clear, as
trained mice displayed reduced BW due to reduced fat mass
(Figures S3B and S3C) and a marked improvement in treadmill
performance, maximal oxygen consumption (VO2 max), glucose
tolerance, and insulin sensitivity (Figures S3D and S3H).
In the liver, hierarchical clustering analyses revealed that the
gene expression patterns of EODF mice were clearly set apart
from those of other groups (Figure 4A). This indicates that
EODF has a profound impact on liver gene expression that is
(legend on next page)
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Figure 3. SIRT1 Transgenesis Does Not
Enhance EODF Effects on Mitochondrial
Metabolism
Mice were euthanized after an overnight fast, and
tissues were collected for analysis.
(A) Protein extracts from frozen tissues were used
to measure the markers indicated. sk, skeletal.
(B) Respirometry analyses in permeabilized EDL
muscle fibers, liver homogenates, BAT homoge-
nates, and eWAT tissue were conducted using
high-resolution respirometry. CI respiration, CI +
CII respiration, and maximal ETS capacity were
examined as described in the Supplemental
Experimental Procedures. O2 flux values are ex-
pressed relative to tissue wet weight. All values
are presented as mean ± SEM of n = 5–6 mice
per genotype and group. *p < 0.05, significant
difference between AL- and EODF-fed mice. $ in-
dicates significant difference between genotypes
at p < 0.05.
See also Supplemental Experimental Procedures
and Figure S2.not mimicked by SIRT1 transgenesis. In particular, livers from
WT-EODF mice displayed marked enrichment in gene sets
relating to DNA replication and mismatch repair (Figure S4A;Figure 2. SIRT1 Overexpression Does Not Mimic the Metabolic Changes of EODF
(A and B) Daily activity (A) and heat production (B) of mice were recorded using a comprehensive laboratory
(C and D) Intraperitoneal glucose tolerance test (ipGTT) (C) and intraperitoneal insulin tolerance test (ITT)
Supplemental Experimental Procedures. Analyses of area under the curve (AUC) and area above the curve
(E–G) Hyper-insulinemic-euglycemic clamps were performed on WT and WT-EODF mice. Glucose infusion r
infusion (2 and 10 mU/kg/min) (E), glucose fluxes (F), and glucose uptake in different tissues—epididymal
represented.
All values are presented as mean ± SEM of n = 6–12 mice for each genotype and group. $p < 0.05, significant
significant difference between AL- and EODF-fed mice; **p < 0.03, statistical significant difference betwee
significant difference between AL- and EODF-fed mice. $$$p<0.01, statistical significant difference between
See also Supplemental Experimental Procedures and Figure S1.
2072 Cell Reports 14, 2068–2075, March 8, 2016 ª2016 The Authorsdata not shown). In the skeletal muscle,
we did not observe major differences
between WT, WT-EODF, and Tg mice
(Figure 4B). In contrast, EX led to a clearly
differentiated gene expression pattern
(Figure 4B). Accordingly, and in contrast
to SIRT1 transgenesis and EODF,
EX enhanced oxidative-phosphorylation
(OXPHOS)-related gene expression (Fig-
ure S4B) and mitochondrial respiration in
skeletal muscle (Figure S3G).
In BAT, EX and EODF led to disparate
gene expression profiles. Interestingly,
the profile in Tg BAT resembled, to a
certain extent, that of exercisedmice (Fig-
ure 4C), in line with the fact that both inter-
ventions enhance mitochondrial respira-
tion in BAT (Figure 3B; Figure S3H).
The transcriptomic changes induced by
SIRT1 trangenesis and EODF in BAT are
diametrically different. Exemplifying this,PPARa target genes, while upregulated in the BAT of Tg mice
(Boutant et al., 2015), were downregulated by EODF (Fig-
ure S4C). As in liver, EODF promoted dramatic changes inanimal monitoring system (CLAMS).
(D) analyses were performed as described in the
(AAC) are present on the top right, respectively.
ate (GIR) measured at two different levels of insulin
WAT, skeletal (sk) muscle, liver, and BAT—(G) are
difference between genotypes. *p < 0.05, statistical
n AL- and EODF-fed mice; ***p < 0.01, statistical
genotypes.
Figure 4. Transcriptomic Analyses Compar-
ing the Effects of CR, EX, and SIRT1 Trans-
genesis
(A–D) Microarrays were performed on liver (A),
skeletal muscle (B), BAT (C), and eWAT (D) from
WT, Tg, WT-EODF, and WT-EX mice. Hierarchical
clustering was performed based on the most sig-
nificant transcripts selected by the pairwise com-
parisons.
(E) Venn diagrams representing the overlap be-
tween upregulated or downregulated genes in
response to EODF and SIRT1 transgenesis versus
WT mice.
See also Figures S3 and S4 and Tables S1 and S2.eWAT transcription profiles that clearly were segregated from
those of the other groups (Figure 4D). In line with the respirom-
etry tests, OXPHOS gene sets were very significantly upregu-
lated in the eWAT upon EODF (Figure S4D). Altogether, these
data suggest that (1) EODF promotes dramatic transcriptomic
changes in liver, WAT, and BAT, but not in skeletal muscle; (2)
the gene expression profile changes induced by SIRT1 transgen-
esis do not mimic those of EODF; and (3) SIRT1 transgenesis
does not mimic the transcriptional effects of EX in skeletal mus-
cle, although similarities were observed in BAT.
Next, we evaluated the overlap between the gene expression
changes elicited by EODF and SIRT1 transgenesis compared to
WT mice. There was a very marginal overlap between the genes
that are significantly upregulated or downregulated in response
to EODF and SIRT1 transgenesis (Figure 4E; Figures S4E–S4H;
Tables S1 and S2). In addition, while a number of genes were
significantly affected by both EODF and SIRT1 transgenesis,
many of them were regulated in opposite directions (Tables S1
and S2). This is especially the case in liver, where out of the 51
genes regulated by both EODF and SIRT1 transgenesis, 44 didCell Reports 14, 2068–207so in opposing ways (Table S1). Interest-
ingly, SIRT1 was significantly downregu-
lated at the mRNA level in BAT upon
EODF (Table S2). Also, as predicted by
hierarchical clustering, liver, BAT, and
eWAT are the tissues where EODF elicited
a higher number of significant transcrip-
tional changes (Figure 4E). In contrast,
SIRT1 transgenesis had minor effects on
eWAT, while BAT displayed the highest
number of significant changes. Hence,
the transcriptional changes induced by
EODF are largely different from, and
even contradictory to, those induced by
SIRT1 transgenesis.
DISCUSSION
SIRT1 loss-of-function models suggest
that CR requires SIRT1 to promote a num-
ber of metabolic and behavioral adapta-
tions (Boily et al., 2008; Chen et al., 2005;
Mercken et al., 2014). This led to the spec-ulation that SIRT1-activating strategies could act as CRmimetic.
SIRT1 activation via STACs has further strengthened this notion,
as they improve insulin sensitivity (Mercken et al., 2012), a para-
digm of CR. However, overlapping effects, such as increased in-
sulin sensitivity, do not necessarily indicate mimetic strategies,
as what happens between EX and EODF (Figure 4).
Here, we demonstrate that genetic SIRT1 gain of function
neither mimics nor boosts the metabolic effects of EODF.
EODF and SIRT1 transgenesis lead to opposite effects in BAT,
as revealed by histology, metabolic, transcriptomic, and respi-
rometry analyses. In turn, EODF leads to dramatic changes in
the transcriptional profiles of liver and eWAT, which are barely
affected in Tg mice, at least at the ages tested in our study.
Also, both EODF and canonical CR (Chen et al., 2005) lead to
increased daily activity, while SIRT1 transgenesis decreases
daily activity (Banks et al., 2008; Boutant et al., 2015). These ob-
servations argue that SIRT1 is required for the adaptations to
CR, but the activation of SIRT1 is not, per se, a CR mimetic. In
line with this, SIRT1 transgenesis did not lead to increased life-
span, a well-recognized effect of CR regimes (Herranz et al.,5, March 8, 2016 ª2016 The Authors 2073
2010). Additionally, SIRT1 transgenesis also failed to mimic or
enhance the protective effects of EODF on cancer in p53 hetero-
zygous mice (Herranz et al., 2011).
Our results indicate that endogenous SIRT1 levels are enough
to fully adapt to EODF. This is in line with previous observations
in other SIRT1 transgenic mouse models. By submitting muscle-
specific SIRT1 KOmice to a 40%decrease in daily caloric intake,
it was shown that CR requires SIRT1 to enhance insulin-stimu-
lated muscle glucose uptake (Schenk et al., 2011). Under similar
regimes, however, muscle-specific SIRT1 overexpression did
not improveCR-inducedadaptations (Whiteet al., 2013). In agree-
ment, CR failed to enhance lifespan in SIRT1KOmice, but hetero-
zygous expression of SIRT1 was enough to ensure similar CR-
induced lifespan extension as in WT mice (Mercken et al., 2014).
While EODF and classic CR have been commonly used as CR
regimes, a molecular underpinning of potential differences be-
tween these interventions has never been fully addressed. In
this sense, several studies have reported changes in SIRT1
expression in liver, WAT, and muscle upon CR (Chen et al.,
2008; Nisoli et al., 2005) that were not observed in our EODF
study. Nevertheless, it has been shown that EODF and CR
display a very significant overlap in their transcriptional profiles
for different tissues, including liver, muscle, and WAT (Pearson
et al., 2008). Similarly, classic CR and EODF render very compa-
rable outcomes on glucose and lipid management (Mattson and
Wan, 2005), even in humans (Barnosky et al., 2014). Despite
these observations, further efforts will be needed to evaluate
whether the discrepancies between the SIRT1 gain of function
and EODF scenarios can be extrapolated to other CR regimes.
The impact of CR onmitochondrial biogenesis has also been a
matter of debate (Hancock et al., 2011). In our model, EODF trig-
gered modest increases in mitochondrial function in eWAT, but
not in skeletal muscle, liver, or BAT. SIRT1 has been shown to
regulate mitochondrial biogenesis in skeletal muscle cells via
the deacetylation of PGC-1a (Canto´ et al., 2009; Gerhart-Hines
et al., 2007). However, muscle-specific SIRT1 KO mice do not
display major differences in mitochondrial marker levels (Men-
zies et al., 2013; Philp et al., 2011). Supra-physiological overex-
pression of SIRT1 in skeletal muscle has rendered conflicting
results, as both increases (Chalkiadaki et al., 2014; Price et al.,
2012) and decreases (Gurd et al., 2009) in muscle oxidative
capacity have been reported. This might be due to the different
strategies used to overexpress SIRT1 in these studies. However,
in line with previous reports (Boutant et al., 2015; Brandon et al.,
2015; Pfluger et al., 2008; White et al., 2014), our results suggest
that mild SIRT1 overexpression does not enhance mitochondrial
biogenesis in skeletal muscle.
Altogether, this study demonstrates that, while SIRT1 activa-
tion holds a strong therapeutic promise for the management of
metabolic disease, the source of these benefits can be clearly
disentangled from those of CR regimes in the shape of intermit-
tent fasting.EXPERIMENTAL PROCEDURES
Animal Care
SIRT1 Tgmice expressing a single additional copy of the SIRT1 gene per allele
(SIRT1Tg/Tg) have already been described (Boutant et al., 2015). Only male2074 Cell Reports 14, 2068–2075, March 8, 2016 ª2016 The Authorsmice were used. Mice were kept in a standard temperature- and humidity-
controlled environment with a 12-hr:12-hr light:dark cycle. Mice had nesting
material and AL access to water and a commercial low-fat diet (LFD)
(D12450J, Research Diets). The CR study was performed on 12-week-old
mice as EODF. At the beginning of the experiment, food was removed from
the hopper and returned approximately 24 hr later. This pattern of food
removal and return took place daily for 3 months. The phenotyping started af-
ter 12 weeks of EODF, and mice were sacrificed after a total of 18 weeks of CR
and an overnight fast. Overnight fasts prior to tests and sacrifice were always
done after the feeding day in the EODF group. All animal experiments were car-
ried out according to national Swiss and EU ethical guidelines and approved
by the local animal experimentation committee under license number 2519.
Phenotyping procedures can be found in the Supplemental Experimental
Procedures.
Transcriptomic Analyses
Illumina microarrays were used to profile the gene expression levels of
approximately 25,000 genes in the liver, skeletal muscle, BAT, and eWAT
of WT and SIRT1Tg/Tg mice (n = 6 per group). The RNA samples were
prepared using the Illumina TotalPrep RNA Amplification Kit and were then
hybridized on MouseRef-8 v2.0 Expression BeadChips. Raw microarray
data were analyzed for quality control and extracted using the Illumina
GenomeStudio Software, and they were then analyzed using Partek Geno-
mics Suite (GS) software. Basically, raw data were log2 transformed and
quantile normalized prior to statistical analysis. Statistics consisted of a
one-way ANOVA in each tissue sample followed by pairwise comparisons.
The Benjamini-Hochsberg multiple testing correction method was applied.
A corrected p value <0.05 was considered as significant. Venn diagrams
were generated using a free online tool (http://bioinformatics.psb.ugent.be/
webtools/Venn/).
Statistical Analyses
Statistical analyses were performed with Prism software (GraphPad). Differ-
ences between two groups were analyzed using Student’s t test (two-tailed),
and multiple comparisons were analyzed by ANOVA with a Bonferroni post
hoc test. A p value <0.05 was considered significant. Data are expressed as
means ± SEM.
Further experimental procedures can be found in the Supplemental
Information.
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